0.36 USD
▼-0.08-17.24%
盘后 0.37 +2.47%
2026-11-20
市值
$26.82M
市盈率
—
EPS
-1.04
股息率
—
52 周区间
0.35 – 1.58
成交量
255.91K
Beta
-0.19
目标价
6.00
52W 低 0.3552W 高 1.58
价格走势
公司简介
Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson’s disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer’s disease and Progeria. The company was formerly known as Metallo The...